Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

HK Type 4 license through Ballingal Investment Advisors Ltd. 

I'm a highly experienced sell-side analyst with in excess of 22 years of covering Asia Pacific equities, the past 19 years immersed in event strategies encompassing M&A risk arbitrage, directional long/short, stub trades and restructuring.  

My background also includes accountancy (liquidation/bankruptcy/receivership) earlier in my career and as a chief financial officer of a global commodity company based in the US and Mexico.

Pan-Asia Catalysts/Events

Quiddity Advisors

Event-Driven

<p>On Sunday, KKR and <strong><a href="https://www.smartkarma.com/entities/17148" target="_blank" data-smartkarma-citation="entities:17148:1">LCY Chemical Corp (1704 TT)</a></strong> jointly <a href="https://www.businesswire.com/news/home/20180722005024/en/Proposed-Acquisition-LCY-Chemical-Corp.-KKR-Consortium" target="_blank">announced</a> the signing of a US$1.56bn share exchange agreement for a consortium led by KKR to acquire all of the issued and outstanding shares of LCY for TWD56/share. This includes a TWD2.90/share dividend, with an ex-date this Friday (27th). (The Taiwan Stock Exchange announcement - in Chinese; there are no English ones, yet - is PDF'ed at the end of this insight). </p>
<h2>Conclusions First</h2>
<ul>
<li>The offer appears optically light. The offer price…</li>
</ul>

On Sunday, KKR and LCY Chemical Corp (1704 TT) jointly announced the signing of a US$1.56bn share exchange agreement for a consortium led by KKR to acquire all of the issued and outstanding shares of LCY for TWD56/share. This includes a TWD2.90/share dividend, with an ex-date this Friday (27th). (The Taiwan Stock Exchange announcement - in Chinese; there are no English ones, yet - is PDF'ed at the end of this insight). 
Conclusions First

The offer appears optically light. The offer price…


KKR's "Low-Ball" Offer for LCY Chemical Likely to Succeed